Does REGORAFENIB Cause Hepatotoxicity? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Hepatotoxicity have been filed in association with REGORAFENIB (Stivarga). This represents 0.5% of all adverse event reports for REGORAFENIB.
47
Reports of Hepatotoxicity with REGORAFENIB
0.5%
of all REGORAFENIB reports
11
Deaths
19
Hospitalizations
How Dangerous Is Hepatotoxicity From REGORAFENIB?
Of the 47 reports, 11 (23.4%) resulted in death, 19 (40.4%) required hospitalization, and 5 (10.6%) were considered life-threatening.
Is Hepatotoxicity Listed in the Official Label?
Yes, Hepatotoxicity is listed as a known adverse reaction in the official FDA drug label for REGORAFENIB.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which REGORAFENIB Alternatives Have Lower Hepatotoxicity Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR